India grows into leading Asian prospect for exporters
This article was originally published in Clinica
Medical device companies looking for growth opportunities in the developing world could find that India offers significantly better prospects than other Asian countries, according to the US Health Industry Manufacturers Association (HIMA).
You may also be interested in...
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
Through its partnership with majority stakeholder Nanjing King-Friend Biochemical Pharmaceutical, Meitheal Pharmaceuticals has received FDA approval for enoxaparin, a generic rival to Lovenox.